Recipes for diffuse correlation spectroscopy instrument design using commonly utilized hardware based on targets for signal-to-noise ratio and precision.
Journal
Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630
Informations de publication
Date de publication:
01 Jun 2021
01 Jun 2021
Historique:
received:
22
02
2021
revised:
18
04
2021
accepted:
04
05
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
Over the recent years, a typical implementation of diffuse correlation spectroscopy (DCS) instrumentation has been adapted widely. However, there are no detailed and accepted recipes for designing such instrumentation to meet pre-defined signal-to-noise ratio (SNR) and precision targets. These require specific attention due to the subtleties of the DCS signals. Here, DCS experiments have been performed using liquid tissue simulating phantoms to study the effect of the detected photon count-rate, the number of parallel detection channels and the measurement duration on the precision and SNR to suggest scaling relations to be utilized for device design.
Identifiants
pubmed: 34221659
doi: 10.1364/BOE.423071
pii: 423071
pmc: PMC8221932
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3265-3281Informations de copyright
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.
Déclaration de conflit d'intérêts
The role in the project of all the companies and their employees involved has been defined by the project objectives, tasks, and work packages and has been reviewed by the European Commission (grant agreement No. 688303, LUCA-project). Turgut Durduran is an inventor of a relevant patent (Patent US8082015B2). ICFO has equity ownership in the spin-off company HemoPhotonics S.L.. Udo Weigel is the CEO, has equity ownership and is an employee of the company. The potential financial conflicts of interest and objectivity of research have been monitored by ICFO’s Knowledge & Technology Transfer Department and none were identified. Davide Contini and Alberto Dalla Mora are co-founders of pioNIRS s.r.l., spin-off company from Politecnico di Milano (POLIMI, Italy). Their potential financial conflicts of interest and the objectivity of research has been monitored by POLIMI and none were identified.
Références
J Biophotonics. 2019 Nov;12(11):e201900091
pubmed: 31339649
Appl Opt. 2007 Dec 10;46(35):8506-14
pubmed: 18071383
Biomed Opt Express. 2014 Jul 23;5(8):2769-84
pubmed: 25136500
Opt Express. 2010 Aug 2;18(16):16289-301
pubmed: 20721015
Opt Lett. 2018 Jun 1;43(11):2450-2453
pubmed: 29856401
Biomed Opt Express. 2011 Jul 1;2(7):1969-85
pubmed: 21750773
Neurophotonics. 2019 Jul;6(3):035013
pubmed: 31548976
Opt Express. 2018 Oct 29;26(22):29375-29392
pubmed: 30470102
Appl Phys Lett. 2014 Sep 29;105(13):133702
pubmed: 25378708
Neurophotonics. 2014 Jun 20;1(1):
pubmed: 25593978
Neurophotonics. 2018 Jan;5(1):011015
pubmed: 28948194
J Biomed Opt. 2007 Sep-Oct;12(5):051903
pubmed: 17994886
Pediatr Res. 2019 Oct;86(4):515-521
pubmed: 31234195
Opt Lett. 2020 Jul 1;45(13):3377-3380
pubmed: 32630849
Neurophotonics. 2019 Apr;6(2):025007
pubmed: 31093515
Opt Lett. 2013 May 1;38(9):1401-3
pubmed: 23632498
Med Phys. 2015 Jul;42(7):4000-6
pubmed: 26133600
Opt Express. 2006 Feb 6;14(3):1125-44
pubmed: 19503435
Neurophotonics. 2021 Jan;8(1):015001
pubmed: 33437846
Optica. 2018;5(5):518-527
pubmed: 30417035
Biomed Opt Express. 2018 Apr 04;9(5):2068-2080
pubmed: 29760970
Neurophotonics. 2020 Jul;7(3):035010
pubmed: 32995362
Biomed Opt Express. 2019 Jul 11;10(8):3899-3915
pubmed: 31452983
Biomed Opt Express. 2014 Mar 28;5(4):1275-89
pubmed: 24761306
Hum Brain Mapp. 2010 Mar;31(3):341-52
pubmed: 19650140
J Biomed Opt. 2005 Jul-Aug;10(4):44002
pubmed: 16178636
Biomed Opt Express. 2018 Nov 12;9(12):6170-6185
pubmed: 31065421
J Appl Physiol (1985). 2019 Nov 1;127(5):1328-1337
pubmed: 31513443
J Cereb Blood Flow Metab. 2020 Jan;40(1):187-203
pubmed: 30375917
J Neurotrauma. 2020 Sep 15;37(18):2014-2022
pubmed: 32458719
Rep Prog Phys. 2010 Jul;73(7):
pubmed: 26120204
J Biomed Opt. 2013 Mar;18(3):037001
pubmed: 23455963
Phys Med Biol. 2011 May 21;56(10):3015-32
pubmed: 21508444
Biomed Opt Express. 2015 Sep 10;6(10):3907-18
pubmed: 26504641
J Cereb Blood Flow Metab. 2017 Aug;37(8):2691-2705
pubmed: 28541158
Opt Lett. 2004 Aug 1;29(15):1766-8
pubmed: 15352363
IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386
pubmed: 23243386
Neurophotonics. 2014 Jul;1(1):
pubmed: 25453036
Phys Rev Lett. 1995 Aug 28;75(9):1855-1858
pubmed: 10060408
Neuroimage. 2014 Jan 15;85 Pt 1:51-63
pubmed: 23770408
Optica. 2016 Sep;3(9):1006-1013
pubmed: 28008417
J Biomed Opt. 2012 Jul;17(7):075010
pubmed: 22894482
Phys Med Biol. 2017 Jun 21;62(12):4637-4653
pubmed: 28402286
Opt Lett. 2005 Nov 1;30(21):2915-7
pubmed: 16279468
Opt Lett. 2009 Nov 15;34(22):3556-8
pubmed: 19927209
J Biomed Opt. 2012 Sep;17(9):97004-1
pubmed: 23085922
J Biomed Opt. 2020 Sep;25(9):
pubmed: 32996299
PLoS One. 2016 Jan 27;11(1):e0147851
pubmed: 26815533
Neuroimage. 2014 Jan 15;85 Pt 1:279-86
pubmed: 23370052
Biomed Opt Express. 2017 Oct 27;8(11):5311-5325
pubmed: 29188122
Biomed Opt Express. 2016 Feb 03;7(3):776-97
pubmed: 27231588
Opt Express. 2018 May 28;26(11):14700-14709
pubmed: 29877406
J Neurotrauma. 2020 Dec 1;37(23):2569-2579
pubmed: 32460617
Neurophotonics. 2016 Jan;3(1):015001
pubmed: 27115020
J Neurol. 2019 Apr;266(4):990-997
pubmed: 30739181
J Biomed Opt. 2020 Sep;25(9):
pubmed: 33000571